Relief Therapeutics Holding AG reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CHF 3.24 million. Revenue was CHF 4.55 million compared to CHF 0.891 million a year ago.

Net loss was CHF 26.5 million compared to CHF 14.68 million a year ago. Basic loss per share from continuing operations was CHF 2.4 compared to CHF 1.6 a year ago.